CollPlant Biotechnologies (CLGN) Operating Leases (2019 - 2026)

CollPlant Biotechnologies has reported Operating Leases for 8 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 12.13% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 12.13% YoY), and the FY2025 full-year result was $2.0 million, down 10.68% from the prior year.
• Operating Leases for Q1 2026 stood at $1.9 million, down from $2.0 million in the prior quarter.
• The five-year high for Operating Leases was $2.9 million in Q1 2023, with the low at $1.9 million in Q1 2026.
• Historically, Operating Leases has averaged $2.4 million across 5 years, with a median of $2.4 million in 2024.
• The largest YoY upside for Operating Leases was 11.77% in 2022 against a maximum downside of 22.89% in 2022.
• CollPlant Biotechnologies' Operating Leases stood at $2.4 million in 2022, then gained by 6.42% to $2.5 million in 2023, then slipped by 10.26% to $2.3 million in 2024, then decreased by 10.68% to $2.0 million in 2025, then fell by 8.71% to $1.9 million in 2026.
• The last three Operating Leases figures came in at $1.9 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.